Demand for Evidence Partners’ DistillerSR, which streamlines the medical research process for academics and health organizations has skyrocketed during the COVID-19 pandemic. DistillerSR uses artificial intelligence to sort through biomedical research and aggregate the most relevant studies in a fraction of the time it would take a person to perform the same task manually. What used to take months using Excel spreadsheets is now just a matter of days.
“We had people at different government agencies telling us that given the volume of material coming out around COVID, they could not ever have contemplated even being able to do their jobs without this software,” says CEO Peter O’Blenis, who co-founded the company more than a decade ago. Read more here.